Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

Find Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Near You

Unilateral Versus Bilateral Lung Volume Reduction Surgery for Patients With Severe COPD

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study compares two surgical approaches for patients with severe Chronic Obstructive Pulmonary Disease (COPD) and severe emphysema: unilateral (operating on one lung) versus bilateral (operating on both lungs) lung volume reduction surgery (LVRS).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Suitable target areas in both lungs

• Age ≥ 18 years.

• Speaks and understands Danish or English

• Informed consent obtained

• Usual inclusion criteria in LVRS:

⁃ Moderate to severe COPD with MRC score \> 2 \< 75 years old 17 \< BMI \> 30 FEV1 \> 20% and \< 45% of predicted RV \> 200% of predicted as a sign of relevant hyperinflation DLCO \> 20% of predicted The patient should be in ideal medical treatment and have completed rehabilitation A high-resolution CT \< 3 months old should follow the referral to MDT Absence of nodules suspicious of malignancy on CT scan Absence of significant comorbidity including severe cardiovascular disease LVEF normal Absence of pulmonary hypertension, TI-gradient \< 40 mmHg Absence of chronic or frequent lung infections Smoking abstinence six months prior to surgery Assessed as sufficiently physically fit to undergo surgery and rehabilitation

Locations
Other Locations
Denmark
Rigshospitalet
RECRUITING
Copenhagen
Contact Information
Primary
Alberte Lund, MD
alberte.lund@regionh.dk
+4535458016
Time Frame
Start Date: 2025-03-21
Estimated Completion Date: 2032-07
Participants
Target number of participants: 146
Treatments
Experimental: Bilateral LVRS
Active_comparator: Unilateral LVRS
Sponsors
Leads: Rigshospitalet, Denmark
Collaborators: Medtronic

This content was sourced from clinicaltrials.gov